Abstract
Background
Recently, the prevalence of invasive fungal infections has been on the rise, and one of the prevalent symptoms frequently observed is bone deterioration and bone loss.
Materials and Methods
Using an in vitro model we studied how Aspergillus fumigatus invades the bone. Pathological analysis was then employed to observe the structure and distinctive features of the invading fungal elements within the bone invasion model. Meanwhile, the antifungal effects of itraconazole, voriconazole, posaconazole, and amphotericin B were evaluated.
Results
The pathological findings showed that in the experimental group, fungal spores and hyphae invaded the bone tissue or were observed growing in the vicinity of the bone edge tissues, as indicated by both HE and PAS staining. In contrast, no fungal elements were observed in the control group, indicating that the in vitro bone invasion model of A. fumigatus was successfully constructed. Furthermore, the findings from the antifungal sensitivity test demonstrated that the lowest effective concentrations of antifungal drugs against the bone invasion model were as follows: 4 μg/ml for itraconazole, 0.5 μg/ml for voriconazole, 2 μg/ml for posaconazole, and 2 μg/ml for amphotericin B.
Discussion
The successful construction of the bone invasion model of A. fumigatus has provided a solid basis for future investigations into the mechanisms underlying A. fumigatus bone invasion and the study of its virulence factors. Utilizing bone models is of utmost importance in advancing the development of novel antifungal treatment approaches, as well as in effectively preventing and treating fungal bone invasion and osteolytic diseases.
Similar content being viewed by others
References
Sousa C, Pasini RA, Pasqualotto A, et al. Imaging findings in aspergillosis: from head to toe. Mycopathologia. 2023;188(5):623–41.
Florez-Riaño AF, Ramírez-Sánchez IC. Breakthrough invasive sinusitis by Hormographiella aspergillata in a neutropenic patient receiving voriconazole therapy: a case report and review of breakthrough H. aspergillata infections. Mycopathologia. 2023;188(4):401–7.
Gamaletsou MN, Rammaert B, Bueno MA, et al. Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome. J Infect. 2014;68(5):478–93.
Raz E, Win W, Hagiwara M, Lui YW, Cohen B, Fatterpekar GM. Fungal sinusitis. Neuroimaging Clin N Am. 2015;25(4):569–76.
Zhou W, et al. Managements and prognostic analyses in patients with invasive fungal rhinosinusitis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016;51(8):568–72.
van de Veerdonk FL, Gresnigt MS, Romani L, Netea MG, Latgé JP. Aspergillus fumigatus morphology and dynamic host interactions. Nat Rev Microbiol. 2017;15(11):661–74.
Abad A, Fernández-Molina JV, Bikandi J, et al. What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. Rev Iberoam Micol. 2010;27(4):155–82.
Miyabe S, Koizuka I, Ochi K, et al. Two cases of Aspergillus sinusitis with bone destruction. Auris Nasus Larynx. 2003;30(Suppl):S115–21.
Gabrielli E, Fothergill AW, Brescini L, et al. Osteomyelitis caused by Aspergillus species: a review of 310 reported cases. Clin Microbiol Infect. 2014;20(6):559–65.
Pagella F, Matti E, De Bernardi F, et al. Paranasal sinus fungus ball: diagnosis and management. Mycoses. 2007;50(6):451–6.
Leventakos K, Lewis RE, Kontoyiannis DP. Fungal infections in leukemia patients: how do we prevent and treat them? Clin Infect Dis. 2010;50(3):405–15.
Vallejo C, Barberán J. Empirical antifungal treatment: a valid alternative for invasive fungal infection. Rev Esp Quimioter. 2011;24(3):117–22.
Lee DH, Yoon TM, Lee JK, Joo YE, Park KH, Lim SC. Invasive fungal sinusitis of the sphenoid sinus. Clin Exp Otorhinolaryngol. 2014;7(3):181–7.
Van Daele R, Spriet I, Wauters J, et al. Antifungal drugs: what brings the future? Med Mycol. 2019;57(Suppl_3):S328–43.
McGill TJ, Simpson G, Healy GB. Fulminant aspergillosis of the nose and paranasal sinuses: a new clinical entity. Laryngoscope. 2015;125(4):782.
Reddy CE, Gupta AK, Singh P, Mann SB. Imaging of granulomatous and chronic invasive fungal sinusitis: comparison with allergic fungal sinusitis. Otolaryngol Head Neck Surg. 2010;143(2):294–300.
Tortorano AM, Viviani MA, Biraghi E, et al. In vitro testing of fungicidal activity of biocides against Aspergillus fumigatus. J Med Microbiol. 2005;54(Pt 10):955–7.
Dijksterhuis J, Meijer M, van Doorn T, Samson R, Rico-Munoz E. Inactivation of stress-resistant ascospores of Eurotiales by industrial sanitizers. Int J Food Microbiol. 2018;285:27–33.
Reisberger EM, Abels C, Landthaler M, Szeimies RM. Histopathological diagnosis of onychomycosis by periodic acid–Schiff-stained nail clippings. Br J Dermatol. 2003;148(4):749–54.
Von Lilienfeld-Toal M, Wagener J, Einsele H, Cornely OA, Kurzai O. Invasive fungal infection. Dtsch Arztebl Int. 2019;116(16):271–8.
Chen MM, Shi GH, Dai Y, Fang WX, Wu Q. Identifying genetic variants associated with amphotericin B (AMB) resistance in Aspergillus fumigatus via k-mer-based GWAS. Front Genet. 2023;14:1133593.
Wang HC, Hsieh MI, Choi PC, Wu WL, Wu CJ. Species distribution and antifungal susceptibility of clinical Aspergillus isolates: a multicentre study in Taiwan, 2016–2020. Mycoses. 2023;66(8):711–22.
Pfaller MA, Carvalhaes CG, Castanheira M. Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY antifungal surveillance program (2018–2021) and application of single-site epidemiological cutoff values to evaluate amphotericin B activity. Mycoses. 2023;66(10):854–68.
Fang W, Wu J, Cheng M, et al. Diagnosis of invasive fungal infections: challenges and recent developments. J Biomed Sci. 2023;30(1):42.
Jenks JD, Seidel D, Cornely OA, et al. Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008–2019. Clin Microbiol Infect. 2020;26(6):784.e1-784.e5.
Earle K, Valero C, Conn DP, et al. Pathogenicity and virulence of Aspergillus fumigatus. Virulence. 2023;14(1):2172264.
Mowat E, Lang S, Williams C, McCulloch E, Jones B, Ramage G. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms. J Antimicrob Chemother. 2008;62(6):1281–4.
Roilides E, Simitsopoulou M, Katragkou A, Walsh TJ. How biofilms evade host defenses. Microbiol Spectr. 2015. https://doi.org/10.1128/microbiolspec.mb-0012-2014.
Healy DY, Leid JG, Sanderson AR, Hunsaker DH. Biofilms with fungi in chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2008;138(5):641–7.
Funding
This work was supported by the Key R&D Project of Hubei Province (Health Field) [2022BCE022], the Scientific Research Project of Hubei Provincial Commission of Health [WJ2021M261] and the Scientific research project of Jingzhou Science and Technology Bureau [2023HC43].
Author information
Authors and Affiliations
Contributions
YS (Formal analysis, Visualization, Writing—original draft, Writing—review & editing), MS (Formal analysis, Visualization, Supervision, Specimen acquisition Writing—review & editing), DP (Specimen acquisition), WC (Specimen acquisition), CM (Specimen acquisition), HZ (Conceptualization, Data curation, Formal analysis), YS (Conceptualization, Funding acquisition, Project administration, Supervision, Validation, Writing—review & editing).
Corresponding author
Ethics declarations
Conflict of interest
We declare no conflicts of interest.
Ethical Approval
The experiment adhered to the principles of Good Clinical Practice (GCP) and diligently complied with applicable laws and regulations.The clinical research was conducted in accordance with the approved research plan (Approval No. 2023-016-01) endorsed by the Ethics Committee of Jingzhou Hospital Affiliated to Yangtze University, with the primary aim of safeguarding the health and rights of the study participants.
Additional information
Handling Editor: Ferry Hagen.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shao, Y., Shen, M., Peng, D. et al. Observation of a Bone Invasion Model of Aspergillus fumigatus In Vitro and Analysis of the Antifungal Susceptibility. Mycopathologia 189, 4 (2024). https://doi.org/10.1007/s11046-023-00817-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11046-023-00817-y